News – Page 916 – Endpoints News

SIGN UP

Pfizer to combine its off-patent drug unit with Mylan

6 years ago

Thrashed by a 'surprise' rival, Sanofi writes off $2B on soured hemophilia deal

6 years ago

Novartis’ star blockbuster flunks closely watched PhIII — but they may file for key add-on OK anyway

6 years ago

Failed PhIIIs after a rejection by the FDA spur Sanofi to dump its $1.7B deal with Lexicon on diabetes drug — ...

6 years ago

AbbVie scraps an anti-tau study, and that may foretell more big trouble for a beleaguered Biogen

6 years ago

EMA backs five medicines; Solid Bio raises $60M in private placement

6 years ago

J&J touts their head-to-head win against Sanofi on MS, steering another S1P drug to the FDA

6 years ago

Peer Review: Rubius recruits BD chief; Epizyme hires Novartis vet as CFO

6 years ago

Allergan/Editas finally kick off CRISPR trial — marking first in vivo test of the gene-editing technology

6 years ago

Following EMA, FDA restricts use of high-dose Xeljanz, warning of added risks for the blockbuster JAK

6 years ago

Vertex rushes to assure Wall Street that Jeff Leiden is keeping a hand on the reins as one analyst questions ...

6 years ago

Jupiter biotech scores $56M to defeat herpes, in a field littered with failure

6 years ago

The top 10 pipeline blowups, setbacks and snafus for H1 2019

6 years ago

Nektar takes a hit as the FDA swerves away from opioid reviews — leaving NKTR-181 in limbo

6 years ago

Boston's NeuroBo to use bruised Gemphire to make Nasdaq debut

6 years ago

ICER backs cost-effectiveness of Vascepa, Xarelto; Epizyme's lead drug wins speedy US review

6 years ago

PARP inhibitors sometimes work beyond BRCA-mutations, researchers may finally know why

6 years ago

What makes Hal Barron tick? Look at the people he’s teaming up with at GSK

6 years ago

Vertex's Reshma Kewalramani takes CEO post as longtime vet Jeff Leiden moves to new role

6 years ago

A 2-year-old fledgling biotech steers into PhIII and nabs a quick $565M buyout deal

6 years ago

In a first, Lilly's ready-to-use rescue hypoglycemia powder wins US approval

6 years ago

FDA’s Woodcock weighs in on role of NIH in drug development

6 years ago

Bristol-Myers does it again, disappointing investors with a surprise Opdivo PhIII failure as chemo combo flops

6 years ago

WHO endorses GSK's dolutegravir for HIV; Syapse collaborates with Pfizer on RWE

6 years ago

First page Previous page 913 914 915916917 918 919 Next page Last page